mobiflex and rofecoxib

mobiflex has been researched along with rofecoxib* in 1 studies

Trials

1 trial(s) available for mobiflex and rofecoxib

Article	Year
A randomized crossover trial of tenoxicam compared with rofecoxib for postoperative dental pain control. Anaesthesia and intensive care, 2004, Volume: 32, Issue:6 Two non-steroidal anti-inflammatory drugs, tenoxicam and rofecoxib, were compared for the control of postoperative pain following surgical extraction of bilaterally and symmetrically impacted wisdom teeth performed under intravenous sedation and local anaesthesia. Thirty-five young fit adult patients received each analgesic treatment for four days in a randomized, crossover design. The results suggest statistically better pain relief for the selective COX-2 inhibitor rofecoxib compared to tenoxicam, a traditional NSAID. There were side-effects with both treatments. Abdominal discomfort was significantly more common following rofecoxib compared to tenoxicam. Both analgesics were acceptable to most participants in the trial. Topics: Adolescent; Adult; Confidence Intervals; Cross-Over Studies; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Lactones; Male; Molar, Third; Odds Ratio; Pain Measurement; Pain, Postoperative; Patient Satisfaction; Piroxicam; Probability; Sulfones; Tooth Extraction; Treatment Outcome	2004

Article

Year

A randomized crossover trial of tenoxicam compared with rofecoxib for postoperative dental pain control.

Anaesthesia and intensive care, 2004, Volume: 32, Issue:6

Two non-steroidal anti-inflammatory drugs, tenoxicam and rofecoxib, were compared for the control of postoperative pain following surgical extraction of bilaterally and symmetrically impacted wisdom teeth performed under intravenous sedation and local anaesthesia. Thirty-five young fit adult patients received each analgesic treatment for four days in a randomized, crossover design. The results suggest statistically better pain relief for the selective COX-2 inhibitor rofecoxib compared to tenoxicam, a traditional NSAID. There were side-effects with both treatments. Abdominal discomfort was significantly more common following rofecoxib compared to tenoxicam. Both analgesics were acceptable to most participants in the trial.

Topics: Adolescent; Adult; Confidence Intervals; Cross-Over Studies; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Lactones; Male; Molar, Third; Odds Ratio; Pain Measurement; Pain, Postoperative; Patient Satisfaction; Piroxicam; Probability; Sulfones; Tooth Extraction; Treatment Outcome

2004